StandardAero jumps as investors cite new MRO agreements and upbeat 2026 outlook
StandardAero shares rose 3.23% to $26.69 as investors focused on recent commercial engine-services wins and a reaffirmed 2026 growth outlook. The company’s latest disclosures highlighted 2026 guidance for $6.275–$6.425B revenue, $870–$905M adjusted EBITDA, $270–$300M free cash flow, and $1.35–$1.45 adjusted EPS.
1) What’s moving the stock today
StandardAero (SARO) traded higher today, with the move aligning with renewed investor attention on the company’s recent commercial engine-services momentum and its full-year 2026 financial targets. Recent announcements around expanding MRO relationships—alongside guidance that calls for higher earnings and free cash flow—are supporting sentiment even after prior months’ equity-supply overhang from secondary activity.
2) Recent catalysts in focus
In early March 2026, StandardAero said it signed a General Terms Agreement with AviLease covering MRO support for LEAP and CFM56-7B engines, reinforcing expectations for rising shop-visit volumes as next-generation narrowbody engines mature. Separately, StandardAero disclosed full-year 2026 guidance alongside its Q4 and full-year 2025 report, outlining revenue of $6.275–$6.425 billion, adjusted EBITDA of $870–$905 million, free cash flow of $270–$300 million, and adjusted EPS of $1.35–$1.45—targets that investors often treat as an anchor for valuation as the aftermarket cycle builds. (standardaero.com)
3) Why the tape may be reacting now
With SARO trading below many published analyst targets in late March 2026 commentary, incremental positive newsflow (commercial agreements and fleet-support wins) can have an outsized effect on near-term positioning. The market is also parsing StandardAero’s emphasis on converting earnings to cash in 2026 (via its free-cash-flow target) as a potential counterweight to prior concerns about working-capital intensity in engine-services ramp programs. (ir.standardaero.com)
4) What to watch next
Key follow-ups for SARO include additional announcements tied to LEAP and CFM56 capacity expansion, evidence of sustained margin performance as newer programs move down the learning curve, and any updates on capital allocation that could tighten share supply. Investors will also watch for further large-holder selling activity versus company repurchases, and for order/backlog signals that validate the 2026 guidance range.